According to Shenzhen Salubris Pharmaceuticals's latest financial reports the company's current EPS (TTM) is 0,09642ย โฌ. In 2024 the company made an earnings per share (EPS) of 0,06364ย โฌ an increase over its 2023 EPS that were of 0,06327ย โฌ.